BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11872295)

  • 1. Relationship between acute and late normal tissue injury after postoperative radiotherapy in endometrial cancer.
    Jereczek-Fossa BA; Jassem J; Badzio A
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):476-82. PubMed ID: 11872295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors determining acute normal tissue reactions during postoperative radiotherapy in endometrial cancer: analysis of 317 consecutive cases.
    Jereczek-Fossa BA; Badzio A; Jassem J
    Radiother Oncol; 2003 Jul; 68(1):33-9. PubMed ID: 12885450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time without symptoms and toxicity (TWIST) analysis of adjuvant radiation therapy for endometrial cancer.
    Jereczek-Fossa BA; Badzio A; Jassem J
    Radiother Oncol; 2004 Aug; 72(2):175-81. PubMed ID: 15297136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late complications after postoperative radiotherapy in endometrial cancer: analysis of 317 consecutive cases with application of linear-quadratic model.
    Jereczek-Fossa B; Jassem J; Nowak R; Badzio A
    Int J Radiat Oncol Biol Phys; 1998 May; 41(2):329-38. PubMed ID: 9607348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a role for a brachytherapy vaginal cuff boost in the adjuvant management of patients with uterine-confined endometrial cancer?
    Greven KM; D'Agostino RB; Lanciano RM; Corn BW
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):101-4. PubMed ID: 9747826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late reactions after postoperative high-dose-rate intravaginal brachytherapy for endometrial cancer: a comparison of standardized and individualized target volumes.
    Onsrud M; Strickert T; Marthinsen AB
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):749-55. PubMed ID: 11172958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenocarcinoma of the endometrium treated with combined irradiation and surgery: study of 437 patients.
    Touboul E; Belkacémi Y; Buffat L; Deniaud-Alexandre E; Lefranc JP; Lhuillier P; Uzan S; Jannet D; Uzan M; Antoine M; Huart J; Ganansia V; Milliez J; Blondon J; Housset M; Schlienger M
    Int J Radiat Oncol Biol Phys; 2001 May; 50(1):81-97. PubMed ID: 11316550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer.
    Greven K; Winter K; Underhill K; Fontenesci J; Cooper J; Burke T;
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):168-73. PubMed ID: 15093913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma--a prospective randomized study.
    Sorbe B; Horvath G; Andersson H; Boman K; Lundgren C; Pettersson B
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1249-55. PubMed ID: 21676554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
    Alektiar KM; Venkatraman E; Chi DS; Barakat RR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clinical outcomes and toxicity in endometrial cancer patients treated with adjuvant intensity-modulated radiation therapy or conventional radiotherapy.
    Chen CC; Wang L; Lu CH; Lin JC; Jan JS
    J Formos Med Assoc; 2014 Dec; 113(12):949-55. PubMed ID: 24144528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between acute and late toxicity in 973 prostate cancer patients treated with three-dimensional conformal external beam radiotherapy.
    Jereczek-Fossa BA; Zerini D; Fodor C; Santoro L; Serafini F; Cambria R; Vavassori A; Cattani F; Garibaldi C; Gherardi F; Ferrari A; Rocco B; Scardino E; de Cobelli O; Orecchia R
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):26-34. PubMed ID: 20133085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three or four fractions of 4-5 Gy per week in postoperative high-dose-rate brachytherapy for endometrial carcinoma.
    Rovirosa A; Ascaso C; Sánchez-Reyes A; Herreros A; Abellana R; Pahisa J; Lejarcegui JA; Biete A
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):418-23. PubMed ID: 20800388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravaginal high-dose-rate brachytherapy for Stage IB (FIGO Grade 1, 2) endometrial cancer.
    Alektiar KM; McKee A; Venkatraman E; McKee B; Zelefsky MJ; Mychalczak BR; Hoskins WJ; Barakat RR
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):707-13. PubMed ID: 12062616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic outcome and relation of acute and late side effects in the adjuvant radiotherapy of endometrial carcinoma stage I and II.
    Weiss E; Hirnle P; Arnold-Bofinger H; Hess CF; Bamberg M
    Radiother Oncol; 1999 Oct; 53(1):37-44. PubMed ID: 10624851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma: a prospective, randomized study--quality-of-life analysis.
    Sorbe BG; Horvath G; Andersson H; Boman K; Lundgren C; Pettersson B
    Int J Gynecol Cancer; 2012 Sep; 22(7):1281-8. PubMed ID: 22864336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher-than-expected severe (Grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients.
    Cozzarini C; Fiorino C; Deantoni C; Briganti A; Fodor A; La Macchia M; Noris Chiorda B; Rancoita PM; Suardi N; Zerbetto F; Calandrino R; Montorsi F; Di Muzio N
    Eur Urol; 2014 Dec; 66(6):1024-30. PubMed ID: 24985964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late radiation effects to the rectum and bladder in gynecologic cancer patients: the comparison of LENT/SOMA and RTOG/EORTC late-effects scoring systems.
    Anacak Y; Yalman D; Ozsaran Z; Haydaroğlu A
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1107-12. PubMed ID: 11483319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late urologic effects after adjuvant irradiation in stage I endometrial carcinoma.
    Herwig R; Bruns F; Strasser H; Pinggera GM; Micke O; Rehder P; Gozzi C; Willich N; Hertle L
    Urology; 2004 Feb; 63(2):354-8. PubMed ID: 14972490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Predictive of Receiving Adjuvant Radiotherapy in High-Intermediate-Risk Stage I Endometrial Cancer.
    McGunigal M; Pollock A; Doucette JT; Liu J; Chadha M; Kalir T; Gupta V
    Int J Gynecol Cancer; 2018 Jun; 28(5):882-889. PubMed ID: 29538253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.